Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Otsuka

Status and phase: Completed; Phase 3

Conditions: Body Weight Change; Schizophrenia; Schizoaffective Disorder; Psychotic Disorder

Treatments: Drug: Aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00095524

CN138-122

Details and patient eligibility

About

The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Adult patients diagnosed with schizophrenia or schizoaffective disorder who are currently taking olanzapine.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind